Endothélium et muscle lisse dans le développement et la progression de l’HTAP

Marcos, 2004, Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension, Circ Res, 94, 1263, 10.1161/01.RES.0000126847.27660.69 Sanchez, 2007, Role of endotheliumderived ml chemokine ligand 2 in idiopathic pulmonary arterial hypertension, Am J Respir Crit Care Med, 176, 1041, 10.1164/rccm.200610-1559OC Humbert, 2004, Treatment of pulmonary arterial hypertension, N Engl J Med, 351, 1425, 10.1056/NEJMra040291 Eddahibi, 2006, Cross talk between endothelial and smooth muscle cells in pulmonary hypertension : critical role for serotonin-induced smooth muscle hyperplasia, Circulation, 113, 1857, 10.1161/CIRCULATIONAHA.105.591321 Savale, 2009, Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice, Respir Res, 10, 6, 10.1186/1465-9921-10-6 Tu, 2010, Autocrine FGF2 Signaling Contributes to Altered Endothelial Phenotype in Pulmonary Hypertension, Am J Respir Cell Mol Biol Dewachter, 2006, Angiopoietin/Tie2 pathway infiuences smooth muscle hyperplasia in idiopathic pulmonary hypertension, Am J Respir Crit Care Med, 174, 1025, 10.1164/rccm.200602-304OC